These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

110 related items for PubMed ID: 9137431

  • 21. Paclitaxel and radiotherapy: sequence-dependent efficacy--a preclinical model.
    Niero A, Emiliani E, Monti G, Pironi F, Turci L, Valenti AM, Marangolo M.
    Clin Cancer Res; 1999 Aug; 5(8):2213-22. PubMed ID: 10473108
    [Abstract] [Full Text] [Related]

  • 22. Opioid growth factor enhances tumor growth inhibition and increases the survival of paclitaxel-treated mice with squamous cell carcinoma of the head and neck.
    Jaglowski JR, Zagon IS, Stack BC, Verderame MF, Leure-duPree AE, Manning JD, McLaughlin PJ.
    Cancer Chemother Pharmacol; 2005 Jul; 56(1):97-104. PubMed ID: 15791460
    [Abstract] [Full Text] [Related]

  • 23. Combined gamma-irradiation and subsequent cisplatin treatment in human squamous carcinoma cell lines sensitive and resistant to cisplatin.
    Caney C, Singh G, Lukka H, Rainbow AJ.
    Int J Radiat Biol; 2004 Apr; 80(4):291-9. PubMed ID: 15204706
    [Abstract] [Full Text] [Related]

  • 24. Apoptosis as a predictor of paclitaxel-induced radiosensitization in human tumor cell lines.
    Kurdoglu B, Cheong N, Guan J, Corn BW, Curran WJ, Iliakis G.
    Clin Cancer Res; 1999 Sep; 5(9):2580-7. PubMed ID: 10499636
    [Abstract] [Full Text] [Related]

  • 25. Low-dose fractionated radiation potentiates the effects of Paclitaxel in wild-type and mutant p53 head and neck tumor cell lines.
    Dey S, Spring PM, Arnold S, Valentino J, Chendil D, Regine WF, Mohiuddin M, Ahmed MM.
    Clin Cancer Res; 2003 Apr; 9(4):1557-65. PubMed ID: 12684432
    [Abstract] [Full Text] [Related]

  • 26. p53 mutations and presence of HPV DNA do not correlate with radiosensitivity of gynecological cancer cell lines.
    Rantanen V, Grénman S, Kurvinen K, Hietanen S, Raitanen M, Syrjänen S.
    Gynecol Oncol; 1998 Dec; 71(3):352-8. PubMed ID: 9887230
    [Abstract] [Full Text] [Related]

  • 27. Comparative evaluation of the treatment efficacy of suberoylanilide hydroxamic acid (SAHA) and paclitaxel in ovarian cancer cell lines and primary ovarian cancer cells from patients.
    Sonnemann J, Gänge J, Pilz S, Stötzer C, Ohlinger R, Belau A, Lorenz G, Beck JF.
    BMC Cancer; 2006 Jul 11; 6():183. PubMed ID: 16834771
    [Abstract] [Full Text] [Related]

  • 28. Apoptotic mechanism of paclitaxel-induced cell death in human head and neck tumor cell lines.
    Hsiao JR, Leu SF, Huang BM.
    J Oral Pathol Med; 2009 Feb 11; 38(2):188-97. PubMed ID: 19200178
    [Abstract] [Full Text] [Related]

  • 29. Calcitriol (1,25-dihydroxycholecalciferol) enhances paclitaxel antitumor activity in vitro and in vivo and accelerates paclitaxel-induced apoptosis.
    Hershberger PA, Yu WD, Modzelewski RA, Rueger RM, Johnson CS, Trump DL.
    Clin Cancer Res; 2001 Apr 11; 7(4):1043-51. PubMed ID: 11309356
    [Abstract] [Full Text] [Related]

  • 30. [Dose response curve of paclitaxel measured by histoculture drug response assay].
    Yoshimasu T, Oura S, Hirai I, Kokawa Y, Okamura Y, Furukawa T.
    Gan To Kagaku Ryoho; 2005 Apr 11; 32(4):497-500. PubMed ID: 15853216
    [Abstract] [Full Text] [Related]

  • 31. In vitro chemosensitivity testing of human non-small cell lung cancer cell lines.
    Bepler G, O'Briant K.
    Anticancer Res; 1998 Apr 11; 18(5A):3181-5. PubMed ID: 9858881
    [Abstract] [Full Text] [Related]

  • 32. Paclitaxel-induced apoptosis may occur without a prior G2/M-phase arrest.
    Dziadyk JM, Sui M, Zhu X, Fan W.
    Anticancer Res; 2004 Apr 11; 24(1):27-36. PubMed ID: 15015572
    [Abstract] [Full Text] [Related]

  • 33. Inositol hexaphosphate and paclitaxel: symbiotic treatment of oral cavity squamous cell carcinoma.
    Janus SC, Weurtz B, Ondrey FG.
    Laryngoscope; 2007 Aug 11; 117(8):1381-8. PubMed ID: 17607147
    [Abstract] [Full Text] [Related]

  • 34. Disruption of p53 function in immortalized human cells does not affect survival or apoptosis after taxol or vincristine treatment.
    Fan S, Cherney B, Reinhold W, Rucker K, O'Connor PM.
    Clin Cancer Res; 1998 Apr 11; 4(4):1047-54. PubMed ID: 9563901
    [Abstract] [Full Text] [Related]

  • 35. Enhanced growth inhibition of squamous cell carcinoma of the head and neck by combination therapy of paclitaxel and opioid growth factor.
    McLaughlin PJ, Jaglowski JR, Verderame MF, Stack BC, Leure-Dupree AE, Zagon IS.
    Int J Oncol; 2005 Mar 11; 26(3):809-16. PubMed ID: 15703840
    [Abstract] [Full Text] [Related]

  • 36. [Predictive value of in vitro MTT assay chemosensitivity test of cytotoxic drug activity in cervical cancer].
    Xiao Y, Li JD, Shi HL, Liu JH, Feng YL, Li MD.
    Ai Zheng; 2007 Apr 11; 26(4):386-9. PubMed ID: 17430657
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. 2-methoxyestradiol inhibits hypoxia-inducible factor 1alpha, tumor growth, and angiogenesis and augments paclitaxel efficacy in head and neck squamous cell carcinoma.
    Ricker JL, Chen Z, Yang XP, Pribluda VS, Swartz GM, Van Waes C.
    Clin Cancer Res; 2004 Dec 15; 10(24):8665-73. PubMed ID: 15623651
    [Abstract] [Full Text] [Related]

  • 39. Description of paclitaxel resistance-associated genes in ovarian and breast cancer cell lines.
    Duan Z, Lamendola DE, Duan Y, Yusuf RZ, Seiden MV.
    Cancer Chemother Pharmacol; 2005 Mar 15; 55(3):277-85. PubMed ID: 15565326
    [Abstract] [Full Text] [Related]

  • 40. [Combined effect of Paclitaxel and ionizing radiation. Experimental data of in-vitro and in-vivo models].
    Rübe C, Hampel G, Schuck A, Willich N.
    Strahlenther Onkol; 1996 May 15; 172 Suppl 1():2-5. PubMed ID: 8633269
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.